167 related articles for article (PubMed ID: 35123536)
1. LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer.
Kamakura M; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Kinugawa Y; Nagaya T; Yoshizawa T; Shimizu A; Ota H; Umemura T
Diagn Pathol; 2022 Feb; 17(1):21. PubMed ID: 35123536
[TBL] [Abstract][Full Text] [Related]
2. Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma.
Kuraishi Y; Uehara T; Kobayashi Y; Nakajima T; Watanabe T; Shimizu A; Ota H; Tanaka E
Pathol Res Pract; 2019 Nov; 215(11):152623. PubMed ID: 31543221
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
4. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
5. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Ota H; Tanaka E
Ann Diagn Pathol; 2020 Oct; 48():151587. PubMed ID: 32829068
[TBL] [Abstract][Full Text] [Related]
6. LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma.
Ehara T; Uehara T; Nakajima T; Kinugawa Y; Kobayashi S; Iwaya M; Ota H; Soejima Y
BMC Cancer; 2021 Mar; 21(1):228. PubMed ID: 33676447
[TBL] [Abstract][Full Text] [Related]
7. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Suga T; Ota H; Tanaka E
Ann Diagn Pathol; 2019 Jun; 40():161-165. PubMed ID: 31100646
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
9. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
10. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
11. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
[TBL] [Abstract][Full Text] [Related]
13. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
14. Leucine-rich repeat-containing G-protein-coupled receptor 5 expression and clinicopathological features of colorectal neuroendocrine neoplasms.
Nakajima T; Uehara T; Kobayashi Y; Kinugawa Y; Yamanoi K; Maruyama Y; Suga T; Ota H
Pathol Int; 2018 Jul; ():. PubMed ID: 30043418
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
[TBL] [Abstract][Full Text] [Related]
16. Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses.
Andrikou K; Santoni M; Piva F; Bittoni A; Lanese A; Pellei C; Conti A; Loretelli C; Mandolesi A; Giulietti M; Scarpelli M; Principato G; Falconi M; Cascinu S
Future Oncol; 2015; 11(7):1037-45. PubMed ID: 25804119
[TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between PD-L1 expression and LGR5 expression in tumor budding of stage II/III colorectal cancer.
Sato K; Uehara T; Nakajima T; Iwaya M; Miyagawa Y; Watanabe T; Ota H
Ann Diagn Pathol; 2021 Jun; 52():151739. PubMed ID: 33862415
[TBL] [Abstract][Full Text] [Related]
18. Correlation of LGR5 expression and clinicopathological features in intrahepatic cholangiocarcinoma.
Yoshizawa T; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Kinugawa Y; Nagaya T; Kamakura M; Shimizu A; Kubota K; Notake T; Masuo H; Hosoda K; Sakai H; Hayashi H; Umemura K; Kamachi A; Goto T; Tomida H; Yamazaki S; Ota H; Soejima Y
Pathol Res Pract; 2022 Apr; 232():153832. PubMed ID: 35287087
[TBL] [Abstract][Full Text] [Related]
19. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
